FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent

BSE3602.5086.6 (+2.46 %)

PREV CLOSE (Rs.) 3515.90

OPEN PRICE (Rs.) 3510.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 20938

TODAY'S LOW / HIGH (Rs.)3510.05 3615.20

52 WK LOW / HIGH (Rs.)2891.45 3615.2

NSE3603.8083.9 (+2.38 %)

PREV CLOSE( Rs. ) 3519.90

OPEN PRICE (Rs.) 3523.40

BID PRICE (QTY) 3603.80 (1342)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 837877

TODAY'S LOW / HIGH(Rs.) 3509.80 3613.90

52 WK LOW / HIGH (Rs.)2886.45 3613.9

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

751.46

Dividend Yield(%)

0.89

TTM EPS (Rs.)

55.79

P/E Ratio

64.58

Book Value (Rs.)

224.33

Face Value (Rs.)

MCap (Rs. in Mn)

1219249.70

Price/Earning (TTM)

46.05

Price/Sales (TTM)

12.59

Price/Book (MRQ)

16.06

PAT Margin (%)

19.08

ROCE (%)

27.82

Incorporation Year : 15-07 1972

Management Info :

Samir Mehta - Chairman - Managing Director

Registered Office :

Address : Torrent House,Off Ashram Road,,
Ahmedabad,
Gujarat-380009

Phone : 079-26599000

Email : investorservices@torrentpharma.com

Website : www.torrentpharma.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

21Jul Allotment of Debentures
Quarterly Results & Inter alia, will also consider the Issue of Unsecure..

18Jul Torrent Pharmaceuticals seeks CCI’s no
Torrent Pharmaceuticals has sought fair trade regulator -- Competition C..

18Jul Torrent Pharmaceuticals gains on seeki
Torrent Pharmaceuticals is currently trading at Rs. 3526.40, up by 22.05..

Financials

	QTR Mar 25	ANNUAL 25
Net Profit	4740	18880
Gross Profit	6220	26100
Operating Profit	8830	36070
Net Sales	24330	96820

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Pfizer (BSE)

5354.75 (1.23%)

M.Cap (Rs. in Cr)24496.77

Cipla (BSE)

1531.10 (2.95%)

M.Cap (Rs. in Cr)123674.79

Solara Active Pharma (BSE)

695.80 (5.85%)

M.Cap (Rs. in Cr)3350.49

Alkem Laboratories (BSE)

5018.45 (0.41%)

M.Cap (Rs. in Cr)60003.10

Shareholding Pattern

	PROMOTERS	68.31%
	NON-INSTITUTION	6.94%
	MUTUAL FUNDS/UTI	4.95%
	FI/BANKS/INSURANCE	1.62%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

Aditya Birla SL Pha...

5.41

LIC MF Healthcare F...

5.10

ICICI Pru Nifty Pha...

4.51

Nippon India Nifty ...

4.50

PGIM India Healthca...

4.08

ITI Pharma & Health...

4.03

HDFC Pharma and Hea...

3.83

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

TORRENT PHARMACEUTICALS LTD.

Smart Quotes

Attention Investors

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Filing complaints on SCORESEasy & quick

Risk Disclosures On Derivatives